4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-000425
Chief Financial Officer gave up 2,536 shares (to pay taxes)
- Chief Financial Officer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Balthaser Kevin · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-01 | Exercise or conversion : show line 1 in the form | +7,500 | 22,961 | D | ||
| 2024-01-01 | Shares withheld for taxes : show line 2 in the form | −2,536 | $1.05 | $2,663 | 20,425 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −7,500 | 22,500 | D |
Loading xslF345X05/doc4.xml…